Cargando…
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
Checkpoint blockade immunotherapy established a new paradigm in cancer treatment: for certain patients curative treatment requires immune reinvigoration. Despite this monumental advance, only 20%–30% of patients achieve an objective response to standard of care immunotherapy, necessitating the consi...
Autores principales: | Chuckran, Christopher A, Liu, Chang, Bruno, Tullia C, Workman, Creg J, Vignali, Dario AA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368550/ https://www.ncbi.nlm.nih.gov/pubmed/32675311 http://dx.doi.org/10.1136/jitc-2020-000967 |
Ejemplares similares
-
Neuropilin-1 is a T cell memory checkpoint limiting long-term anti-tumor immunity
por: Liu, Chang, et al.
Publicado: (2020) -
Regulatory T cell stability is maintained by a neuropilin-1:semaphorin-4a axis
por: Delgoffe, Greg M., et al.
Publicado: (2013) -
Remodulation of the tumor microenvironment by regulatory T cells
por: Liu, Chang, et al.
Publicado: (2015) -
The extent of metalloproteinase-mediated LAG3 cleavage limits the efficacy of PD1 blockade
por: Andrews, Lawrence P, et al.
Publicado: (2015) -
Elucidating the role of Neuropilin-1 in intra-tumoral regulatory T cell stability
por: Overacre, Abigail E, et al.
Publicado: (2015)